Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-11-22

Clinical Trial Update: DIVERT: Diversion of Flow in Intracranial VErtebral and Blood Blister-like Ruptured Aneurysms Trial: A Randomized Trial Comparing Pipeline Flow Diversion and Best-Standard-Treatment [NA]

View source ↗

Summary

The DIVERT trial, a randomized comparison of Pipeline flow diversion versus best-standard-treatment for ruptured intracranial artery aneurysms, has been withdra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Best-Standard-Treatment
  • Pipeline Embolization Device (Flow-diverting stent)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Ruptured Aneurysm of Intracranial Artery | NA | Status: WITHDRAWN